Clinical Trials Browser

Active not recruiting × Recurrence × Paclitaxel × Clear all

NCT03981796 2025-09-03

RUBY

Phase 3 Active not recruiting

785 enrolled 2 FDA

Neoplasms, Recurrence

NCT03315364 2024-07-25

OPTIMAL

Phase 2/3 Active not recruiting

Breast Neoplasms, Recurrence